about
Nuclear and nucleolar targeting of influenza A virus NS1 protein: striking differences between different virus subtypes.Genetic diversity of the 2009 pandemic influenza A(H1N1) viruses in FinlandDetection of influenza A viruses with a portable real-time PCR instrument.The first detection of influenza in the Finnish pig population: a retrospective study.Akt inhibitor MK2206 prevents influenza pH1N1 virus infection in vitro.Impact of influenza B lineage-level mismatch between trivalent seasonal influenza vaccines and circulating viruses, 1999-2012.Pandemic H1N1 2009 influenza A virus induces weak cytokine responses in human macrophages and dendritic cells and is highly sensitive to the antiviral actions of interferons.Validation and diagnostic application of NS and HA gene-specific real-time reverse transcription-PCR assays for detection of 2009 pandemic influenza A (H1N1) viruses in clinical specimens.Surveillance of influenza in Finland during the 2009 pandemic, 10 May 2009 to 8 March 2010.Antibody responses against influenza A(H1N1)pdm09 virus after sequential vaccination with pandemic and seasonal influenza vaccines in Finnish healthcare professionals.Improving influenza virological surveillance in Europe: strain-based reporting of antigenic and genetic characterisation data, 11 European countries, influenza season 2013/14.Minor changes in the hemagglutinin of influenza A(H1N1)2009 virus alter its antigenic properties.Complete Genome Sequences of Influenza A/H1N1 Strains Isolated from Patients during the 2013-2014 Epidemic Season in Finland.Effectiveness of the live attenuated and the inactivated influenza vaccine in two-year-olds - a nationwide cohort study Finland, influenza season 2015/16.Full-Genome Sequences of Influenza A(H1N1)pdm09 Viruses Isolated from Finnish Patients from 2009 to 2013.Mid-season real-time estimates of seasonal influenza vaccine effectiveness in persons 65 years and older in register-based surveillance, Stockholm County, Sweden, and Finland, January 2017Early oseltamivir treatment of influenza in children 1-3 years of age: a randomized controlled trial.2015/16 seasonal vaccine effectiveness against hospitalisation with influenza A(H1N1)pdm09 and B among elderly people in Europe: results from the I-MOVE+ project.HA1 domain of influenza A (H3N2) viruses in Finland in 1989-1995: evolution, egg-adaptation and relationship to vaccine strains.Reduced cross-protection against influenza A(H3N2) subgroup 3C.2a and 3C.3a viruses among Finnish healthcare workers vaccinated with 2013/14 seasonal influenza vaccine.Comparative Analysis of Whole-Genome Sequences of Influenza A(H1N1)pdm09 Viruses Isolated from Hospitalized and Nonhospitalized Patients Identifies Missense Mutations That Might Be Associated with Patient Hospital Admissions in Finland during 2009 tInfluence of antigenic drift on the intensity of influenza outbreaks: upper respiratory tract infections of military conscripts in Finland.Low 2016/17 season vaccine effectiveness against hospitalised influenza A(H3N2) among elderly: awareness warranted for 2017/18 season.Reappearance of influenza B/Victoria/2/87-lineage viruses: epidemic activity, genetic diversity and vaccination efficacy in the Finnish Defence Forces.Influenza vaccination of dialysis patients: cross-reactivity of induced haemagglutination-inhibiting antibodies to H3N2 subtype antigenic variants is comparable with the response of naturally infected young healthy adults.[Influenza viruses--a challenge for vaccinations].Deposition of respiratory virus pathogens on frequently touched surfaces at airportsInfluenza A/Fujian/411/02(H3N2)-lineage viruses in Finland: genetic diversity, epidemic activity and vaccination-induced antibody responseRecent influenza B viruses in Europe: a phylogenetic analysisVaccination-induced HI antibody to influenza A(H1N1) viruses in poorly primed adults under circumstances of low antigenic driftEvolution of influenza A(H1N1) viruses during a period of low antigenic drift in 1986–91: sequence of the HA1 domain of influenza A/Finland/158/91
P50
Q27865187-BCD7081A-4639-440A-99DE-69751068B358Q28475863-609D800A-078F-478F-8EDD-3B9FDECC1CBDQ30224724-740BBCCC-6006-4E93-BAB4-AF781BA1D602Q30353706-19D8BF35-3A28-48B4-B08A-B7A7873786A0Q30361598-D7DA1B12-A8DC-49A7-A68D-7BD686211C28Q30365872-2EECC453-CDBE-427F-AD8B-E399125202A0Q30382867-06A04C8C-2839-4E27-9F84-698AFFCB413CQ30400351-F0F289E7-1217-449D-9A44-AF7A63BCB56BQ30405277-CC12DF39-4569-4CCB-B296-BB5CA7B11179Q30420571-9FD34C52-5685-4211-AB5A-698FBCE0E40DQ31137989-D9C0B67F-01D6-4ACE-B7A3-C7D464E9E5F3Q34055754-6AC56E17-ADC0-46D9-8601-AA739E682DA7Q35171715-955F0E63-9169-4CAB-A96E-E10E9386AD33Q37355256-BFC0DCE6-257C-489B-87CB-D22A7A41D8C9Q37488305-362E2FD2-0847-453F-B46F-A50B01391732Q37708550-3EF43EDB-EA73-4A1D-B9AF-CEA7D6EAAD12Q38500366-106620BF-C1AE-4BDC-AE7D-69F4515BC6ECQ40087098-F92342EE-395F-4064-9BB3-1E8552B8265CQ41252059-1D7DC72F-0F2F-4A9F-9D90-8BCE95EF92C4Q41486408-5E9DC787-2683-4D5E-AF4A-445D65B546A3Q41529396-E858EE8B-8979-4247-A709-6C493CF24462Q42616272-B0F04820-0E1B-4A62-B692-3E62E184FAC2Q47135577-FBF9AD0C-DA2B-40BF-8CE4-660C04AED3B4Q47819261-155D071B-66ED-42B7-AD72-C32847C52FC8Q50715906-E673AE2D-BCA9-4DC4-B84A-0C60668DF5FAQ51195983-89877AC0-182A-437F-B653-59127FB631DAQ57093820-39EF5731-C260-470B-A800-7C776092B65EQ57102935-B0A00196-11E0-4846-BDA6-1E2E73EDAFF6Q57303231-C58DCD50-7B88-4304-90D8-65C381B8FA17Q57303234-E4E56D7E-455A-40F7-9803-1C49E7DCEC3FQ57303235-3EA5C5A4-9570-4D39-BEDA-0FDD63A20118
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Niina Ikonen
@ast
Niina Ikonen
@en
Niina Ikonen
@es
Niina Ikonen
@nl
type
label
Niina Ikonen
@ast
Niina Ikonen
@en
Niina Ikonen
@es
Niina Ikonen
@nl
prefLabel
Niina Ikonen
@ast
Niina Ikonen
@en
Niina Ikonen
@es
Niina Ikonen
@nl
P106
P31
P496
0000-0003-0724-8888